Small Molecules

03 May 2007 Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
03 May 2007 Anadys Presents Results From Its NS5b HCV Program at International Conference on Antiviral Research
03 May 2007 YM Biosciences Reports Aerolef(TM) Randomized Phase Iib Trial Meets Primary Endpoint In Patients With Post-Surgical Pain
02 May 2007 Up and down with cholesterol management
02 May 2007 deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
02 May 2007 Trigen's innovative platelet adhesion inhibitor, PR-15, successfully completes first-in-man Phase I study
02 May 2007 Sciele Pharma Signs Exclusive License Agreement with LifeCycle Pharma A/S To Market a New Formulation of Fenofibrate in 120 mg and 40 mg Dosage Strengths
02 May 2007 Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
02 May 2007 Transport Pharmaceuticals Initiates Patient Enrollment In Phase 2 Study Of Solovir System For Herpes Labialis
02 May 2007 Hollis-Eden Pharmaceuticals Cleared by FDA to Initiate Phase I Clinical Trial with HE3286 in Treating Metabolic Disorders
02 May 2007 Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
02 May 2007 Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show
02 May 2007 Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
02 May 2007 Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
02 May 2007 Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
02 May 2007 Sirion Therapeutics Initiates Two Phase III Clinical Trials
02 May 2007 Optimer Pharmaceuticals Initiates Second Phase 3 Trial of OPT-80 for CDAD
02 May 2007 Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
01 May 2007 Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
01 May 2007 InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
01 May 2007 Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
01 May 2007 Interim report about clinical trial of BF-200 ALA in actinic keratosis
28 Apr 2007 Diovan(R) achieved 40% reduction in stroke and cardiovascular events in landmark Jikei Heart Study
28 Apr 2007 Kyowa Hakko in-licenses ARQ 197, an anticancer agent in clinical development, from the US company ArQule.
28 Apr 2007 Submission of New Drug Application for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top